QT
PRAX icon

Quantbot Technologies’s Praxis Precision Medicines PRAX Stock Holding History

Quantbot Technologies’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47
Closed -$1.78K – 1888
2025
Q1 		$1.78K Buy
+47
New +$2.94K ﹤0.01% 1403
2023
Q2 		– Sell
-160
Closed -$1.94K – 1883
2023
Q1 		$1.94K Buy
+160
New +$6.75K ﹤0.01% 1469
2022
Q3 		– Sell
-1,403
Closed -$51K – 1985
2022
Q2 		$51K Buy
1,403
+1,330
+1,822% +$142K ﹤0.01% 1299
2022
Q1 		$11K Buy
73
+46
+170% +$9.45K ﹤0.01% 1452
2021
Q4 		$7K Buy
+27
New +$7.92K ﹤0.01% 1349

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Quantbot Technologies's PRAX Position: Q2 2025 in Review

Quantbot Technologies sold out of Praxis Precision Medicines (PRAX) in Q2 2025, closing a stake of 47 shares — an estimated $1.78K sold.

Quantbot Technologies first reported a position in PRAX in Q4 2021 and held it in 5 quarters. The position peaked at $51K in Q2 2022. 143 funds tracked by Wall St. Rank hold PRAX as of Q2 2025.

  • Quantbot Technologies reported no remaining Praxis Precision Medicines position as of Q2 2025 after selling out during the quarter.
  • Quantbot Technologies sold 47 Praxis Precision Medicines shares in Q2 2025, an estimated $1.78K.
  • Quantbot Technologies first reported a position in Praxis Precision Medicines in Q4 2021 and held it in 5 quarters.
  • Quantbot Technologies's Praxis Precision Medicines position peaked at $51K in Q2 2022.
  • 143 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2025.

Based on Quantbot Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.